KẾT QUẢ ĐIỀU TRỊ THỞ OXY DÒNG CAO TRONG VIÊM TIỂU PHẾ QUẢN Ở TRẺ NHŨ NHI

admin admin, Nguyễn Hữu Nhân, Nguyễn Thị Gia Hạnh, Nguyễn Thị Gia Hạnh, Hồ Thị Thanh Phương, Võ Thành Nhân, Lê Văn Công

##plugins.themes.vojs.article.main##

Abstract

Objectives: Evaluate the effectiveness of high-flow nasal cannula therapy (HFNC) in infants with bronchiolitis admitted to the emergency department of City Children's Hospital during the period from January 2024 to June 2024.


Methods: Prospective descriptive study of cases series.


Results: There were 30 children with bronchiolitis admitted to the emergency department at City Children's Hospital during the period from January 2024 - June 2024, receiving high flow nasal cannula oxygen therapy (HFNC) after failure with standard oxygen therapy, average age of 6.8 months old, and male/female ratio: 1.1/1. Clinical manifestations before HFNC breathing included 93.3% tachypnea, 86.7% chest indrawing, 100% wheezing, 80% snoring sounds, 46.7% whistling sounds, 13.3% nostril flaring, 66.7% tachycardia, modified bronchiolitis score of 7.1 ± 1.3, SpO2: 91.3 ± 1.5%. The results showed improvement in infants’ respiratory failure such as tachypnea rate, chest indrawing, improved modified bronchiolitis score, SpO2, at 6 hours and 24 hours of HFNC. The successful treatment rate for HFNC is 86.7%. HFNC breathing time 48.7 ± 3.4 hours. No complications of HFNC ventilation and no deaths were documented.


Conclusion: Research shows that respiratory support with HFNC for infants with bronchiolitis failing to standard of oxygen therapy improves respiratory status as well as clinical outcomes of patients.

##plugins.themes.vojs.article.details##

References

1. Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007;335(7628):1037-1041. https://doi.org/10.1136/bmj.39374.600081.ad
2. Dalziel SR, Haskell L, O'Brien S et al. Bronchiolitis. The Lancet 2022;400(10349):392-406. https://doi.org/10.1016/s0140-6736(22)01016-9
3. Goebel J, Estrada B, Quinonez J et al. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clinical pediatrics 2000;39(4):213-220. https://doi.org/10.1177/000992280003900404
4. Mayfield S, Bogossian F, O'Malley L et al. High‐flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. Journal of paediatrics and child health. 2014;50(5):373-8.
5. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane database Syst Rev 2014;(6):CD001266. https://doi.org/10.1002/14651858.cd001266.pub4
6. Moreel L, Proesmans M. High flow nasal cannula as respiratory support in treating infant bronchiolitis: a systematic review. Eur J Pediatr 2020;179(5):711-718. https://doi.org/10.1007/s00431-020-03637-0
7. Pedersen MB, Vahlkvist S. Comparison of CPAP and HFNC in management of bronchiolitis in infants and young children. Children (Basel) 2017;4(4):28. https://doi.org/10.3390/children4040028
8. Lin J, Zhang Y, Xiong L. High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysis. Arch Dis Child 2019;104(6):564-576. https://doi.org/10.1136/archdischild-2018-315846